Mayo Clinic Rochester/St. Mary's Hospital

Rochester, Minnesota 55902

We've found

1 trials

at this facility

A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Rochester, MN

Use our guide to learn which trials are right for you!